Baseline ECOG performance status 0 versus 1 as a modifier of treatment benefit from adding an immune checkpoint inhibitor to chemotherapy: A systematic review and meta-analysis

Critical Reviews in Oncology/Hematology · Elsevier

Аннотация

Publication date: December 2026 Source: Critical Reviews in Oncology/Hematology, Volume 228 Author(s): Wafa Ali Asaad, Salah Ameen Abdu, Yueying Zhou, Guo Cheng, Li Ning

Читать у издателя →

Похожие статьи